chrisvoncsefalvay/vaers-outcomes huggingface dataset:
4/28/2022 at 0914 Employee called the Employee Health COVID-19 Vaccine Nurse Support Line to report symptoms post COVID-19 booster vaccine. Vaccine Name - Pfizer Vaccine Date - 4/27/2022  Booster Dose - Yes Location - Left Deltoid Date of Symptom Onset ? 4/27/2022 Symptoms ?  Headache; Headache is Causing Dizziness when Getting Out of Bed & Unsteady Gait when Walking; Generalized Body Ache & Heaviness; Tingling Left Hand & Fingers Last Day of Work and Shift ? Tuesday, 4/26/22 /  Mo-Fr (830a-5p) / Missed Work: Today, 4/28/22 Home Remedies ?  Ibuprofen 600 mg Every 6 Hours Any Improvement ? Yes (During the time medicine is taken)
I contracted COVID-19 on 06/16/2022 with symptoms of congestion, sore throat, myalgia, and fatigue. I received monoclonal antibodies on 06/20/2022. I was ill for 3 days before my symptoms began to resolve. I am experiencing lingering post nasal drip, but all of my other symptoms have resolved.
2 lumpy hives that became 1 hive directly above site of pneumonia vax site rt deltoid;hives the size of marbles;stiff neck;instructed to apply ice to area;
Severe episode of diarrhea - lasting 10 days. This is in follow-up to report (s) previously sumbitted on 2/14/2008:with 3/4/2008 Information has been received from a physician concerning an 8-week-old male with no medical history or allergies who on 07-NOV-2007 was vaccinated with PO with the first dose of ROTATEQ(Lot #657519/1129U). Concomitant vaccinations administered on that same day included with first dose in the right thigh of PEDIARIX (Lot #AC218128AB), the first dose in the left thigh of ACTHIB (Lot #UF196AA) and the first dose in the left thigh of PREVNAR (B70743A). On 07-NOV-2007, the patient developed persistant severe diarrhea. No laboratory/diagnostic tests were performed as medical attention was not sought. On 16-NOV-2007, the patient recovered. Additional information is not expected.
Received 1st Bexsero then  Trumenba; This case was reported by a pharmacist via call center representative and described the occurrence of interchange of vaccine products in a male patient who received Men B NVS (Bexsero) for prophylaxis.   Co-suspect products included meningococcal B recom vaccine + aloh + omv pre-filled syringe device (Bexsero Pre-Filled Syringe Device) injection syringe for prophylaxis and MENINGOCOCCAL B VACCINE (TRUMENBA) for prophylaxis.   On an unknown date, the patient received the 1st dose of Bexsero, Bexsero Pre-Filled Syringe Device and TRUMENBA. On an unknown date, unknown after receiving Bexsero and Bexsero Pre-Filled Syringe Device, the patient experienced interchange of vaccine products. On an unknown date, the outcome of the interchange of vaccine products was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 02-FEB-2023 Reporter's comment: The registered pharmacist reported that patient received the first dose of Bexsero then received a non-GSK Trumenba dose as a second dose. The pharmacist wanted to know about how to proceed with Bexsero series. The reporter unable to provide any additional details on vaccines. The reporter did not consent to follow up. Additional Supportive Information: The patient received Trumenba vaccine instead of Bexsero, which led to interchange of vaccine products.
Fever & rash 22APR92; t103.4; sz lasting 1-3 minutes; shaking x 1; OM & conjunctivitis;
Dizziness and headache for 2 hours, with mild abdominal pain, starting several hours after vaccine administration (HPV4 [Merck] and influenza Fluzone Quad MDV.
This spontaneous report as received from a pharmacist refers to approximately 76 years old female. The patient drug reactions/allergies were reported to codeine and sulfa. On 30-JAN-2014 the patient was vaccinated with ZOSTAVAX lot # J007210, Expiry date-20-SEP-2014, route subcutaneous and patient developed redness and swelling at the injection site, developed a bruise further down from the injection site after the redness and swelling resolved. The outcome of patient developed redness and swelling at the injection site was reported as recovered/resolved. The outcome of developed a bruise further down from the injection site was reported as not recovered/not resolved. The patient sought medical attention. No product quality complaint was involved. The causality assessment was not provided. Additional information has been requested.
5/24/2021 fever that lasted for 6 days. 5/26/2021 telehealth visit because face was getting red. Was told to rest and drink plenty of fluids. 5/29/2021 went to emergency room and admitted to hospital. 5/31/2021 discharge.
I was administered the COVID-19, on Saturday 1/30/21, 9:55 a.m.  1.  Saturday night (11:50 p M.)  I noticed a barely noticeable hum in my left ear.   2.  It became more noticeable the following day when using the telephone, the voice of the recipient of my call was intermittently heard with a buzzing sound.  3. trying to eliminate allergies as the cause, I began taking allergy capsules. The buzz has remained and has accelerated to a small degree.  4. The buzz is only in the left ear and continues with heightened telephone voice reception.  5. Increase sound of buzzing continues today. 02/04/2021
pt recv vax 10OCT96 & OCT96 pt devel lesions;by NOV96 the original lesions crusted over;however, new lesions devel;
Intense increase in volume of ringing in my ears sometime around my second dose.  I have had mild tinnitis for >5 years, but sudden increase in volume (and absolute volume) of ringing was noticeable.  Whereas previously I had to concentrate or focus to hear it, it is now loud and intrusive-- much harder to ignore, much more disruptive to sleep, thought, etc.
I was awoken around 1 in the morning to severe calf muscle cramps - right and left leg, fever, body aches all over for about 15 hours.  Tylenol, rest and water.
HISTORY OF PRESENT ILLNESS:  HPI Patient is a male presenting to the emergency department with concerns regarding left-sided facial droop.  The patient tells me that he received a COVID-19 vaccine (1st dose) 10 days ago.  Patient states that he went to sleep around 23:00 last night.  He woke up this morning with left-sided facial droop and inability to close his eye completely on the left.  Patient presented to the emergency department for evaluation.  He denies any symptoms otherwise.  He denies any facial numbness, but states that her rather feels like it is ?paralyzed.?  Patient denies any numbness or tingling in his arms or legs.  He denies any unilateral arm or leg weakness.  He denies any visual changes.  No blurry or double vision.  He denies any difficulty with speech or finding words.  He denies any headache or dizziness.  No chest or abdominal pain.  No nausea or vomiting.  No fevers or chills.  No flu-like symptoms.  He denies any loss of taste.  He denies any numbness or tingling in his tongue or lips.  He has no symptoms otherwise. There is no problem list on file for this patient.   No past medical history on file.  Reviewed and negative.  He denies any personal medical history.  Denies any family history of strokes or personal history of strokes.   Vital signs reviewed.  Patient evaluated.  Based on exam and history, it is consistent with left-sided Bell's palsy.  He has no other neurological symptoms and his neurological exam aside from the facial droop is otherwise unremarkable.  I have low concern for stroke based on evaluation today.  He has involvement of the forehead muscles.  At this point, I did discuss with him that this is Bell's palsy and he will be treated with prednisone and valacyclovir .  I do not feel additional workup indicated.  He was agreeable.   He was given an eye shield that he was given eye lubricant to help avoid dry eye.  I did discuss with him that this also may be related to the vaccine given recent administration.  I discussed that he should talk to his doctor about this prior to his 2nd dose.  Patient instructed to monitor symptoms and all questions were addressed.  He was discharged in stable condition       Follow-up Information     No Results Physician, MD.         BLOOD PRESSURE SCREENING: HTN (>/=140/90), recommend follow up with PCP within 1 month. Orders Placed This Encounter Medications ? hypromellose (GENTEAL) 0.3 % GEL ophthalmic gel     Sig: Apply 1 Application to left eye if needed for Dry Eyes.     Dispense:  10 g     Refill:  0 ? valACYclovir (VALTREX) 500 MG tablet     Sig: Take 2 tablets by mouth 2 times daily for 7 days.     Dispense:  28 tablet     Refill:  0 ? predniSONE (DELTASONE) 20 MG tablet     Sig: Take 3 tablets by mouth daily for 7 days.     Dispense:  21 tablet     Refill:  0 ? predniSONE (DELTASONE) tablet 60 mg ? valACYclovir (VALTREX) tablet 1,000 mg
swelling and redness of rt 4th toe. -- suspect chilblains worsening psoriasis
She got her vaccine, a young girl was there, she gave her the dose really fast.  When she did it she could tell that she gave it high on her arm as she felt it. The one prior she hardly felt it at all.  Within 24 hours she could not raise her left arm at all. Within 2-3 days she could not move it and she had a severe rash of heat under her arm.  She Googled the AE and it could be an injury caused Sirva, where it can lock up the shoulder muscle where the injection site was given incorrectly at.  She tried PT at home that she saw online and within 7 days she could move it.  She went to see her PCP and told her what she felt, and he said that he had never heard of the Sirva injury and he also gave her some PT to do and examined her arm and told her she did not have as much strength in that shoulder as she did in the other.  Over time her shoulder gets better, but she still cannot raise it without severe pain.  She has flare ups at times, and it will sometimes run under her arm, almost like she has a pain in her left chest area.  Over times if she continues to lift it and do as much PT as possible it will free the arm up. She is concerned over time what kind of problems is she going to have down the road with her arm from the vaccine.  She had been laid off of work at that time and drawing her unemployment benefits and was not called back to work and is out of work, and still out of work.  She now is going to be limited to what she can lift due to the pain she has in the arm.  She does not know if it's triggered going into a sac that is causing the flare ups of pain or what it can cause.  As of yesterday she is trying to read a little bit and finding out what can happen.  Her PCP told her if she had any more issues by her next visit then maybe they should do an X-ray or further testing. The pain is not in the top of her shoulder but in the side where the arm runs.  Ibuprofen does not alleviate the pain.
Subcutaneous injection on the back o f the right arm.  Was red/sore/painful - widespread redness on arm from elbow to scapula. Took 500mg Tylenol
Presented to the ER on 3/19 at 23:57 with 2 days of worsening shortness of breath. HR 60, Pulse Ox: 85% on Room air. Placed on BiPAP. could not maintain oxygen, intubated. The patient rapidly decompensated and went into cardiac arrest with PEA. ACLS performed for 35 minutes without the ability to reverse. Patient expired at 0222 on 3/20/21.
Narrative:  Injection reaction. Pale, diaphoretic, pupils dilated, short episode of  seizure like activity (per PCP) following receipt of both Tdap and Pneumovax.  Patient had tetanus in past. Provider suspects reaction related to Pneumovax. EMS  transferred patient to local ED. Discharged to home from ED with diagnosis of  vasovagal episode.
Received called that the area of injection site was red, small whelps noted below injection site that looked like "ant bites" .  Called health department medical director, she recommended he be seen by primary care provider for evaluation, if unable to be seen for evaluation, try Benadryl if rash is itchy or looks to him like hives.  I called and spoke with "friend" patient's language is okay,  Explained and friend states "he is at work".  I called today at 7:30 to check on him again.  VAERS form filled out.
On 3-11-21 at 0930, I developed low grade headache up neck over top left side of head in morning, by 1300 hours I felt very crappy similar to how it feels days after a fever breaks when having the influenza. At bedtime 3-11-21, I had a fever 100.1. At 0100, fever rose to 101.1. At 0500 fever rose to 102.6. During day on 3-12-21, I felt like I had the flu, fever broke mid-morning. on 3-13-21, I felt OK. On 3-15 and 16, I felt like I generally like I  had a flue bug. I felt better days later and then around March 21-24th I've had a pretty continuous headache and neck ache which I have not had before the  vaccine. Lack of energy and feeling crappy. Scheduled for second vaccine April 2nd.
A report has been received from a Health Professional concerning a 12 year old, Male subject, who had been receiving FLUMIST quadrivalent (intranasal). FLUMIST quadrivalent (intranasal) started on an unknown date. The patient experienced multiple patients received a half a dose of FLUMIST quadrivalent which started on 28-Oct-2014. The outcome of the event of multiple patients received a half a dose of FLUMIST quadrivalent is unknown. The report was considered to be non-serious.
No Adverse Event; administered primary series dose that was expired.; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administered primary series dose that was expired.) and NO ADVERSE EVENT (No Adverse Event) in a  patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. 082B22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 30-Nov-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 30-Nov-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (administered primary series dose that was expired.). On an unknown date, the patient experienced NO ADVERSE EVENT (No Adverse Event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (administered primary series dose that was expired.) and NO ADVERSE EVENT (No Adverse Event) outcome was unknown.        The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown.   For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No Adverse Event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (administered primary series dose that was expired.).    No concomitant medicine were reported. It was reported that the vaccine was removed from the refrigerator on November 9th. No treatment medicine were reported.   Most recent FOLLOW-UP information incorporated above includes: On 01-Dec-2022: Live follow up received and updated iNarrative supplement.
The medical assistant administered Pneumococcal Polysaccharide instead of PPCV13.  No adverse effects noted. Parent notified.
pt recv vax 28MAR96 & 9APR96 pt devel 20-30 varicella lesions;presented to MD & was dx w/chicken pox;It was noted that the pt might have been exposed to varicella disease prior to vax;titers suggest pt w/poss disease but f/u info n/a;
experiencing "all of the listed side effects." / not feeling well; This case was reported by a consumer via call center representative and described the occurrence of feeling unwell in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 27th January 2021, the patient received the 2nd dose of Shingrix. On 28th January 2021, 1 days after receiving Shingrix, the patient experienced feeling unwell. On an unknown date, the outcome of the feeling unwell was not recovered/not resolved.   It was unknown if the reporter considered the feeling unwell to be related to Shingrix.  Additional information was provided as follows: The age at vaccination was not reported. On 27th January 2021, the patient received 2nd dose of Shingrix. The reporter stated that, she experienced all of the listed side effects and refused to answer any questions as she was not feeling well enough to do so. Limited information was provided. The reporter did not consent to follow up.
Pain and swelling at injection site, weakness in injected arm, slight pain and some swelling of under-arm lymph nodes.
first dose in 11FEB2022, second on 7MAR2022; This case was reported by a other health professional via call center representative and described the occurrence of drug dose administration interval too short in a 56-year-old female patient who received Herpes zoster (Shingrix) (batch number 5F953, expiry date 20th April 2023) for prophylaxis.   Concomitant products included Herpes zoster (Shingrix).   On 7th March 2022, the patient received the 2nd dose of Shingrix. On 7th March 2022, unknown after receiving Shingrix, the patient experienced drug dose administration interval too short. On an unknown date, the outcome of the drug dose administration interval too short was unknown.  Additional details reported were as follows: The reporter was a medical assistant. On 11th February 2022, the patient received 1st dose of Shingrix, batch number 5F953, expiry date 20th April 2023. The patient received 2nd dose of Shingrix earlier than recommended time frame, which led to shortening vaccination schedule. The consent to follow up was given.
pt exp intense vomiting & diarrhea for 3 days post vax & partial left arm paralysis, sweating & low grade fever. pt also had a 20 lb weight loss but has regained 8 lb. nerves there/ no reflexes. pt has not recovered from left arm para
Headache; Body aches; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) and MYALGIA (Body aches) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Apr-2021 at 3:30 PM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Apr-2021, the patient experienced HEADACHE (Headache) and MYALGIA (Body aches). At the time of the report, HEADACHE (Headache) and MYALGIA (Body aches) outcome was unknown. Not Provided          No concomitant medications reported by investigator No treatment medications provided by the reporter.
About 5-6 weeks after vaccine my tinnitus has gotten really worse, it was louder and constant.
tired; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (tired) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030L20A and 039K20A) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 20-Feb-2021, the patient experienced FATIGUE (tired). At the time of the report, FATIGUE (tired) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 99.9 °F (High) 99.9.     mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No concomitant medications were reported.  Treatment reported was none for adverse event.
PATIENT REPORTED THAT 30 MINUTES AFTER ADMINISTRATION SHE EXPERIENCED WEAKNESS, DIZZINESS, NAUSEA, DIARRHEA  SHORTNESS OF BREATH, AND RED ITCHY HANDS WHICH LASTED 30-45 MINUTES. ONE HOUR AFTER THE ADMINISTRATION, HER SYMPTOMS HAD RESOLVED WITHOUT TREATMENT.
1.  Significant worsening of depression and anxiety, and insomnia, now requiring medication, in the weeks following second vaccine.   2.  Bouts of tremors, reported by patient, starting about a day after his second vaccine.
Immunisation anxiety related reaction; the patient began to experience heart racing.; This is a spontaneous report from a non-contactable healthcare professional. A 35-years old female adult patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot number: unknown), via unspecified route of administration in the unspecified anatomical site (at the age of 35-year-old at vaccination) on 12 March2021 as a single dose, for COVID-19 Immunization. The patient's medical history and concomitant medications were not reported. The patient did not have any allergies to medications, foods or other products The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. The patient was not diagnosed with COVID-19 prior to vaccination and not been tested for COVID-19. On 12 March 2021, the patient experienced During her 15-minute waiting period after the injection, the patient began to experience heart racing. The patient diagnosed as (Differential Diagnosis: Vaccine-Related Anxiety (include misc mental health). The patient was received treatment for the event with water to reduce anxiety. The Clinical outcome of the event heart racing was recovered. The Patient is Stable to go home and follow up with PCP. No further information expected.
6 weeks after receiving the 2nd shot "my" current IBS condition went from 2 on a scale of 1-10 to a 10; This is a spontaneous report from a contactable consumer, the patient. A 72-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 20Mar2021 (at the age of 72-years-old) as a single dose for COVID-19 immunisation. Medical history included irritable bowel syndrome (IBS) which was ongoing. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient's concomitant medications included gabapentin (MANUFACTURER UNKNOWN), thioctic acid (ALPHA LIPOIC ACID) and unspecified hydrochloride (MANUFACTURER UNKNOWN); all for unknown indications from unknown dates and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9266) via an unspecified route of administration in the left arm on an unknown date at 00:00 as a single dose for COVID-19 immunisation. On 09May2021 at 14:00, 06 weeks after receiving the second dose of vaccine, the patient's current IBS condition went from 2 on a scale of 1 to 10 to a 10. It was reported that it was urgent and multi bowel movement (BM) diarrhea episodes were happening suddenly almost overnight. These were subsided but only after going gluten free and eliminating many foods from the patient's diet that she had previously been able to consume. It was reported that the patient was very concerned about getting the booster. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event 6 weeks after receiving the 2nd shot "my" current IBS condition went from 2 on a scale of 1-10 to a 10 was not resolved at the time of this report.
L thigh started to swell afternoon after iz. Continued to get worse. L thigh from crease in leg to knee were red hot and very swollen. Extends half way around leg. Appeared slightly ecchymatic. Child afebrile. Leg painful. Tx-soaks in cool water and Motrin.
patient developed red rash and swelling to injection site. area warm to touch and about the size of an adult palm. reaction to left deltoid